SEC Form 4Coverage since Jul 2, 2026
$REGN insider trading
Over the last 12 months, Regeneron Pharmaceuticals insiders reported no purchases and 1 sale totaling $130K across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $130K 1 event
- Events · 12m
- 1 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $REGN · 12Mvia TradingView
Top insiders · 12m
RYAN ARTHUR F—1× · $130K
All insider trades
1 event
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | RYAN ARTHUR FD | ▼ Sale | 200 | $650.15 | $130K | -1.1% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $REGN feed.